AKEBIA THREAPEUTICS INC
AKBA·00972D105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
AKBA (AKEBIA THREAPEUTICS INC) is held by 102 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($22.8M), VANGUARD CAPITAL MANAGEMENT LLC ($12.9M), AQR CAPITAL MANAGEMENT LLC ($10.4M). Net institutional sentiment: Mixed.
102
Holders
(10 Elite)
$111.4M
Total Value
64% (107)
Consensus
68 buying - 39 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 2, 2026 · Insiders Aug 10, 2026 · Activists May 12, 2026 · Congress none
InsiderBPButler John P.Exercise 350K shAug 6, 2026
InsiderOEOstrowski ErikSell $62KJun 29, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 115
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
415 holders · $876.7B
415 holders · $298.4B
400 holders · $151.2B
397 holders · $413.6B
394 holders · $97.5B
393 holders · $111.1B
390 holders · $229.8B
385 holders · $302.3B
385 holders · $51.7B
382 holders · $113.5B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer